Abiraterone Accord Європейський Союз - норвезька - EMA (European Medicines Agency)

abiraterone accord

accord healthcare s.l.u. - abirateronacetat - prostata neoplasmer - endokrin terapi - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Lynparza 100 mg Норвегія - норвезька - Statens legemiddelverk

lynparza 100 mg

abacus medicine a/s - olaparib - tablett, filmdrasjert - 100 mg

Vetoryl 5 mg Норвегія - норвезька - Statens legemiddelverk

vetoryl 5 mg

dechra regulatory b.v. - trilostan - kapsel, hard - 5 mg

Akeega Європейський Союз - норвезька - EMA (European Medicines Agency)

akeega

janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - prostatic neoplasmer, kastrering-resistant - antineoplastiske midler - treatment of adult patients with prostate cancer.

Certican 0.25 mg Норвегія - норвезька - Statens legemiddelverk

certican 0.25 mg

novartis norge (2) - everolimus - dispergerbar tablett - 0.25 mg

Certican 0.1 mg Норвегія - норвезька - Statens legemiddelverk

certican 0.1 mg

novartis norge (2) - everolimus - dispergerbar tablett - 0.1 mg